← Back to Discover
Patient Square Capital LP
Period ended Sep 30, 2026 · Latest filing Nov 10, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $626,679,055
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $281,988,637
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $40,230,960
- UNITED THERAPEUTICS CORP DEL · COM · 91307C102 · shares: $33,964,040
- ARGENX SE · SPONSORED ADR · 04016X101 · shares: $26,849,480
- PHARVARIS N V · COM · N69605108 · shares: $25,650,188
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $24,061,860
- BELITE BIO INC · SPONSORED ADS · 07782B104 · shares: $22,365,294
- MIRUM PHARMACEUTICALS INC · COM · 604749101 · shares: $20,002,320
- ZAI LAB LTD · ADR · 98887Q104 · shares: $15,580,373
- DEFINIUM THERAPEUTICS INC · COM SHS · 24477V105 · shares: $14,653,100
Reported holdings
23 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 7,710,928 shares | $281,988,637 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 196,000 shares | $40,230,960 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 62,677 shares | $33,964,040 |
| ARGENX SE | SPONSORED ADR | 04016X101 | — | 28,000 shares | $26,849,480 |
| PHARVARIS N V | COM | N69605108 | — | 808,644 shares | $25,650,188 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 243,000 shares | $24,061,860 |
| BELITE BIO INC | SPONSORED ADS | 07782B104 | — | 131,700 shares | $22,365,294 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 234,000 shares | $20,002,320 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 591,510 shares | $15,580,373 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 385,000 shares | $14,653,100 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 1,056,269 shares | $13,139,986 |
| DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | — | 1,105,606 shares | $13,001,927 |
| BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | — | 33,500 shares | $12,258,990 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 361,927 shares | $11,588,903 |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | — | 410,000 shares | $10,590,300 |
| BIONTECH SE | SPONSORED ADS | 09075V102 | — | 105,421 shares | $10,362,884 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 212,500 shares | $9,741,000 |
| VAXCYTE INC | COM | 92243G108 | — | 166,000 shares | $9,445,400 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | — | 84,000 shares | $9,390,360 |
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | — | 4,550,000 shares | $7,280,000 |
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | — | 2,007,485 shares | $5,560,733 |
| INVENTIVA SA | ADS | 46124U107 | — | 1,221,225 shares | $4,506,320 |
| HARROW INC | COM | 415858109 | — | 145,000 shares | $4,466,000 |